Top

Published in:

01-06-2008 | Original Paper

Microscopic Peliosis of Pancreatic Islets Associated with Thrombotic Thrombocytopenic Purpura

Authors: Vesselin Belovejdov, Diana Staribratova, Dorian Dikov

Published in: Pathology & Oncology Research | Issue 2/2008

Abstract

Peliosis is a rarely seen histological finding with unexplained fully etiology and pathogenesis. It is presented as cyst-like blood filled cavities. The presence of peliosis in the endocrine part of the pancreas is extremely rarely reported microscopic phenomenon. The authors provide histological, histochemical, immunohistochemical and ultrastructural investigation of microscopic peliosis in the pancreas from an autopsy case with thrombotic trombocytopenic purpura. The findings give ideas for a wide range of pathophysiological and morphogenetic comments of such an unusual morphologic presentation.

Corpa MVN, Bacchi MM, Bacchi CE et al (2004) Peliosis hepatis associated with lymphoplasmacytic lymphoma. Arch Pathol Lab Med 128:1283–1285PubMed

Kovacs K, Horvath E, Asa S et al (1986) Microscopic peliosis of pancreatic islets in a woman with MEN-1 syndrome. Arch Pathol Lab Med 110:607–610PubMed

Berzigotti A, Magalotti D, Zappoli P et al (2006) Peliosis hepatic as an early histological finding in idiopathic portal hypertension: a case report. World J Gastroenterol 12(22):3612–3615PubMed

Tsokos M, Erbersdobler A (2005) Pathology of peliosis. Forensic Sci Int 149 (1):25–33PubMedCrossRef

Zafrani ES, Cazier A, Baudelot AM et al (1984) Ultrastructural lesions of the liver in human peliosis. A report of 12 cases. Am J Pathol 114(3):349–359

Warfel KA, Ellis GH (1982) Peliosis of the spleen. Report of a case and review of the literature. Arch Pathol Lab Med 106(2):99–100PubMed

Czapar CA, Weldon-Linne CM, Moore DM et al (1986) Peliosis hepatic in acquired immunodeficiency syndrome. Arch Pathol Lab Med 110(7):611–613PubMed

Gulubova M (2002) Immunohistochemical localization of collagen Type III and Type IV, laminin, tenascin and α-smooth muscle actin (αSMA) in the human liver in peliosis. Pathol Res Pract 198:803–812PubMedCrossRef

Korner M, Gebbers J-O (2002) Peliosis of the spleen and haemolytic anemia. Histopathology 41:179–180PubMedCrossRef

10.

Koehler JE, Sanchez MA, Garrido CS et al (1997) Molecular epidemiology of Bartonellainfections in patients with bacillary angiomatosis–peliosis. The N Eng J Med 337 (26):1876–83CrossRef

11.

Coire CI, Horvath E, Kovacs K et al (1997) Cushing’s syndrome from an ectopic pituitary adenoma with peliosis: a histological, immunohistochemical and ultrastructural study and review of the literature. Endocr Pathol 8(1):65–74PubMedCrossRef

12.

Lie JT (1985) Pulmonary peliosis. Arch Pathol Lab Med 109(9):878–9PubMed

13.

Chetty R, Kennedy M, Ezzat S et al (2004) Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions. Endocrine Pathology 15(2):141–148PubMedCrossRef

14.

Pernicone PJ, Lie JT (1987) Isolated peliosis of pancreatic islet cell adenoma. Arch Pathol Lab Med 111:690–691PubMed

15.

Ricketts LM, Dlugous M, Luther KB et al (2007) O-fucosylation is require for ADAMTS 13 secretion. J Biol Chem 282(23):17014–23PubMedCrossRef

16.

Girma JP (2006) Biology of von Willebrand factor. Nephrol Ther 2:s143–s148PubMed

17.

Fina L, Molgaard HV, Robertson D et al (1990) Expression of the CD 34 gene in vascular endothelial cells. Blood 75 (12):2417–26PubMed

18.

Delas N, Faurel JP, Wechsled B et al (1982) Association of peliosis and necrotizing vasculitis. Nouv Presse Med 25;11(37):2787

19.

Galbusera M, Noris M, Remuzzi G (2006) Thrombotic thrombocytopenic purpura—then and now. Semin Thromb Hemost 32(2):81–89PubMedCrossRef

20.

Voinchet O, Degott C, Scoazec JY et al (1988) Peliosis hepatis, nodular regenerative hyperplasia of the liver, and light-chain deposition in a patient with Waldenstrom’s macroglobulinemia. Gastroenterology 95:482–486PubMed

Title: Microscopic Peliosis of Pancreatic Islets Associated with Thrombotic Thrombocytopenic Purpura
Authors: Vesselin Belovejdov
Diana Staribratova
Dorian Dikov
Publication date: 01-06-2008
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 2/2008
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-008-9048-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2008

Cell Surface Associated Alpha-l-Fucose Moieties Modulate Human Breast Cancer Neoplastic Progression

The Determination of VEGF and MVD, among Patients with Primary Breast Cancer

Minimal Disease in Sentinel Nodes

The Nottingham Prognostic Index for Invasive Carcinoma of the Breast

Preoperative Systemic Chemotherapy and Pathologic Assessment of Response

Radiological–Pathological Correlation in Diagnosing Breast Carcinoma: The Role of Pathology in the Multimodality Era

Keynote webinar | Spotlight on antibody–drug conjugates in cancer